Correlation Between Shorter Review Times and Reports of Adverse Events for Cardiovascular Devices
A recent analysis, published in Nature Biomedical Engineering has found that longer regulatory review times for high-risk cardiovascular medical devices are correlated with fewer adverse event reports, and a decreased likelihood of such reports citing serious injury or death. This raises questions about the trade-offs between increasing patient access to new devices and ensuring patient safety.
